0 items USD 0.00Search
Your search for "global markets direct lentigen corporation product pipeline review 2014" gave back 83406 results.
Type 2 Diabetes (T2D) Pipeline Analysis” gives comprehensive insight on the various drugs being developed for the treatment of T2D. The global Type 2...
Catalog:
IQ4I
July 2015
Price: USD 3,600.00
The biosimilars are poised to capture an unprecedented position in the biopharmaceutical industry driven by an increased extent of adoption and...
Catalog:
iGATE
October 2016
Price: USD 1,350.00
With much-awaited approval of biosimilar interchangeability by FDA, the dynamics in the much nascent US biosimilars market is about to change with...
Catalog:
Rockville Research
January 2017
Price: USD 1,200.00
This report describes and analyzes the situation of antibody-drug conjugates as of November 2015 regarding: ADC pipeline, ADC technologies, ADC...
Catalog:
La Merie Publishing
November 2015
Price: USD 2,500.00
The present Competitive Intelligence report about Kallikrein Inhibitors & Bradykinin Receptor Antagonists provides a competitor evaluation in the...
Catalog:
La Merie Publishing
June 2014
Price: USD 136.00
Diabetes has emerged as a major economic burden with high associated human and financial cost. It a chronic disease affecting millions of population...
Catalog:
Rockville Research
March 2017
Price: USD 1,100.00
Over the last two decades, the Pharmaceutical/Biotech industry has undergone radical changes. The unprecedented downsizing of the internal discovery...
Catalog:
IQ4I
January 2016
Price: USD 15,000.00
Acute myeloid leukemia is the second frequent type (after acute lymphocytic leukemia) of leukemia diagnosed in infants. About 15% of children from...
Catalog:
LPI
February 2023
Price: USD 3,660.00
Innovation Tracking Factbook 2016 - An Assessment of the Pharmaceutical Pipeline Summary GBI Research’s latest report, "Innovation Tracking...
CBR Pharma Insights
June 2016
Price: USD 2,995.00
Acute myeloid leukemia is the second frequent type (after acute lymphocytic leukemia) of leukemia diagnosed in infants. About 15% of children from...
Catalog:
GIR
January 2023
Price: USD 3,480.00
Acute myeloid leukemia is the second frequent type (after acute lymphocytic leukemia) of leukemia diagnosed in infants. About 15% of children from...
Catalog:
MRRPB5
February 2023
Price: USD 2,900.00
This study focuses on China’s Lung Cancer Treatment Drugs industry forecasts. In the two past decades, the industry has been growing at a fast pace...
Catalog:
Asia Market Information & Development Co.
March 2018
Price: USD 1,800.00
The “Alzheimer’s Disease Therapeutics and Diagnostics Industry Forecast” looks at past sales and reviews total world Alzheimer’s Disease Therapeutics...
Catalog:
LPI
February 2023
Price: USD 3,660.00
Pharmaceutical excipients are inactive substances in the drug which helps in modulating solubility, bioavailability and stability of active...
Catalog:
IQ4I
September 2016
Price: USD 4,500.00
China's demand for Lung Cancer Treatment Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will...
Catalog:
Asia Market Information & Development Co.
March 2018
Price: USD 4,000.00
